zirconium has been researched along with Adenocarcinoma, Basal Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Carrasquillo, JA; Lewis, JS; Lohrmann, C; Lyashchenko, SK; Maffuid, PW; O'Donoghue, JA; O'Reilly, EM; Pandit-Taskar, N; Ruan, S; Scholz, W; Teng, R; Weber, WA | 1 |
| Bedretdinova, D; Deh, K; Gillen, KM; Jin, MM; Kim, J; Lee, R; Liu, Z; Nguyen, T; O' Malley, P; Spincemaille, P; Vedvyas, Y; Wang, Y; Zaman, M | 1 |
| Caen, JD; Dacek, MM; Dilling, TR; Evans, MJ; Fox, IL; Henry, KE; Lewis, JS | 1 |
| Brouwers, AH; de Groot, DJA; de Vries, EGE; Fehrmann, RSN; Gietema, JA; Jorritsma-Smit, A; Kok, IC; Lub-de Hooge, MN; Mahesh, SVK; Menke-van der Houven van Oordt, CW; Moek, KL; Schröder, CP; Suurs, FV; Waaijer, SJH; Wind, TT | 1 |
| Holland, JP; Lewis, JS; May, C; McDevitt, MR; Ruggiero, A; Scheinberg, DA; Sprinkle, SR; Villa, CH | 1 |
| Guo, XF; Qi, CB; Wang, H; Xia, HS; Zhang, HS; Zhao, PX | 1 |
| Eilber, KS; MartÃnez-Salamanca, JI; Secin, FP | 1 |
| Black, PH; Collins, JJ | 1 |
| Hansen, HJ; Krupey, J; Lo Gerfo, P | 1 |
1 trial(s) available for zirconium and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; CA-19-9 Antigen; Follow-Up Studies; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Zirconium | 2019 |
8 other study(ies) available for zirconium and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Contrast Media; Ferric Compounds; Ferrosoferric Oxide; Hyperthermia, Induced; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred NOD; Nanoparticles; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Subcutaneous Tissue; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays; Zirconium | 2020 |
A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Mitogen-Activated Protein Kinase 3; Molecular Targeted Therapy; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Radioisotopes; Signal Transduction; Transferrin; Zirconium | 2019 |
Topics: Adenocarcinoma; Aged; Antibodies, Bispecific; Antibodies, Monoclonal; Carcinoembryonic Antigen; CD3 Complex; Female; Gastrointestinal Neoplasms; GPI-Linked Proteins; Humans; Male; Middle Aged; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; T-Lymphocytes; Tissue Distribution; Zirconium | 2019 |
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
Topics: Actinium; Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Nanomedicine; Nanotubes, Carbon; Neovascularization, Pathologic; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays; Zirconium | 2010 |
Zirconium arsenate-modified silica nanoparticles for specific capture of phosphopeptides and direct analysis by matrix-assisted laser desorption/ionization mass spectrometry.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Arsenates; Cattle; Humans; Molecular Sequence Data; Nanoparticles; Phosphopeptides; Phosphoproteins; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Zirconium | 2012 |
[Limited efficacy of permanent injectable agents in the treatment of stress urinary incontinence after radical prostatectomy].
Topics: Adenocarcinoma; Aged; Drug Evaluation; Glucans; Humans; Injections; Male; Microspheres; Middle Aged; Patient Satisfaction; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Prostheses and Implants; Treatment Outcome; Urinary Incontinence, Stress; Urinary Sphincter, Artificial; Zirconium | 2005 |
Specificity of the carcinoembryonic antigen (CEA).
Topics: Adenocarcinoma; Adult; Antigens; Antigens, Neoplasm; Colonic Neoplasms; Embryo, Mammalian; Female; Gastrointestinal Neoplasms; Gels; Humans; Immune Sera; Methods; Neoplasms; Phosphates; Pregnancy; Radioimmunoassay; Serologic Tests; Zirconium | 1971 |
Demonstration of an antigen common to several varieties of neoplasia.
Topics: Adenocarcinoma; Aged; Animals; Antigens; Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Embryo, Mammalian; Female; Gels; Goats; Humans; Immune Sera; Iodine Isotopes; Lung Neoplasms; Male; Methods; Middle Aged; Neoplasms; Phosphates; Pregnancy; Prostatic Neoplasms; Radioimmunoassay; Zirconium | 1971 |